AAAAAA

   
Results: 1-25 | 26-26
Results: 1-25/26
COMPARISON OF HIGH RESPONDER INHIBITOR FREQUENCY IN RECENT STUDIES OFPREVIOUSLY UNTREATED PATIENTS WITH HEMOPHILIA-A
Authors: EHRLICH HJ BRAY GL GOMPERTS ED
Citation: Hj. Ehrlich et al., COMPARISON OF HIGH RESPONDER INHIBITOR FREQUENCY IN RECENT STUDIES OFPREVIOUSLY UNTREATED PATIENTS WITH HEMOPHILIA-A, Thrombosis and haemostasis, 79(1), 1998, pp. 242-243
SAFETY AND IMMUNOGENICITY OF RECOMBINANT FACTOR-VIII (RECOMBINATE(TM)) IN PREVIOUSLY UNTREATED PATIENTS (PUPS) - A 6.5-YEAR UPDATE
Authors: GRUPPO R BRAY GL SCHROTH P PERRY M GOMPERTS ED
Citation: R. Gruppo et al., SAFETY AND IMMUNOGENICITY OF RECOMBINANT FACTOR-VIII (RECOMBINATE(TM)) IN PREVIOUSLY UNTREATED PATIENTS (PUPS) - A 6.5-YEAR UPDATE, Thrombosis and haemostasis, 1997, pp. 663-663
VIRAL SAFETY RESULTS OF SOLVENT-DETERGENT TREATED FIBRIN SEALANT (HUMAN) ADMINISTERED TO BURN PATIENTS UNDERGOING SKIN-GRAFT PROCEDURES
Authors: BRAY GL GOMPERTS ED LEE M NAVALTA L
Citation: Gl. Bray et al., VIRAL SAFETY RESULTS OF SOLVENT-DETERGENT TREATED FIBRIN SEALANT (HUMAN) ADMINISTERED TO BURN PATIENTS UNDERGOING SKIN-GRAFT PROCEDURES, Thrombosis and haemostasis, 1997, pp. 1033-1033
THE USE OF ROBUST REGRESSION TECHNIQUES TO OBTAIN IMPROVED COAGULATION-FACTOR HALF-LIFE ESTIMATES
Authors: LEE ML SCHROTH P BRAY G GOMPERTS ED
Citation: Ml. Lee et al., THE USE OF ROBUST REGRESSION TECHNIQUES TO OBTAIN IMPROVED COAGULATION-FACTOR HALF-LIFE ESTIMATES, Thrombosis and haemostasis, 1997, pp. 2096-2096
DETERMINATION OF INHIBITOR-RISK AFTER RECEIVING SIGNIFICANT AMOUNTS OF FACTOR-VIII CONCENTRATES
Authors: LEE ML SCHROTH P BRAY G GOMPERTS ED
Citation: Ml. Lee et al., DETERMINATION OF INHIBITOR-RISK AFTER RECEIVING SIGNIFICANT AMOUNTS OF FACTOR-VIII CONCENTRATES, Thrombosis and haemostasis, 1997, pp. 2644-2644
A MULTICENTER STUDY OF RECOMBINANT FACTOR-VIII (RECOMBINATE(TM)) IN PREVIOUSLY TREATED PATIENTS WITH HEMOPHILIA-A
Authors: WHITE GC COURTER S BRAY GL LEE M GOMPERTS ED WHITE G COOPER H HAIRE W BRETTLER D KISKER T HOOTS K SHAPIRO A HALIE MR MANNUCCI PM SCHARRER I BRACKMANN HH GORDON EM GOLDSMITH J HILGARTNER M GILL J LAURIAN Y LARRIEU Y KESSLER C PAI MKR LUSHER JM NEUFELD E EWENSTEIN B SCHULMAN S MORFINI M ADDIEGO JE VERMYLEN JG KRILL CE INGERSLEV J
Citation: Gc. White et al., A MULTICENTER STUDY OF RECOMBINANT FACTOR-VIII (RECOMBINATE(TM)) IN PREVIOUSLY TREATED PATIENTS WITH HEMOPHILIA-A, Thrombosis and haemostasis, 77(4), 1997, pp. 660-667
PROSPECTIVE, RANDOMIZED EVALUATION OF THE EFFICACY OF FIBRIN SEALANT AS A TOPICAL HEMOSTATIC AGENT AT THE CANNULATION SITE IN NEONATES UNDERGOING EXTRACORPOREAL MEMBRANE-OXYGENATION
Authors: ATKINSON JB GOMPERTS ED KANG R LEE M ARENSMAN RM BARTLETT RH RAISBHARAMI K BREAUX CW CORNISH JD HAASE GM RODEN J ZWISCHENBERGER JB
Citation: Jb. Atkinson et al., PROSPECTIVE, RANDOMIZED EVALUATION OF THE EFFICACY OF FIBRIN SEALANT AS A TOPICAL HEMOSTATIC AGENT AT THE CANNULATION SITE IN NEONATES UNDERGOING EXTRACORPOREAL MEMBRANE-OXYGENATION, The American journal of surgery, 173(6), 1997, pp. 479-484
GAMMAGARD(R) AND REPORTED HEPATITIS-C VIRUS EPISODES
Authors: GOMPERTS ED
Citation: Ed. Gomperts, GAMMAGARD(R) AND REPORTED HEPATITIS-C VIRUS EPISODES, Clinical therapeutics, 18, 1996, pp. 3-8
ANAPHYLAXIS AFTER TREATMENT WITH RECOMBINANT FACTOR-VIII
Authors: SHOPNICK RI KAZEMI M BRETTLER DB BUCKWALTER C YANG L BRAY G GOMPERTS ED
Citation: Ri. Shopnick et al., ANAPHYLAXIS AFTER TREATMENT WITH RECOMBINANT FACTOR-VIII, Transfusion, 36(4), 1996, pp. 358-361
ETHICS OF AIDS STUDY
Authors: GOMPERTS ED DONFIELD SM
Citation: Ed. Gomperts et Sm. Donfield, ETHICS OF AIDS STUDY, Science, 274(5293), 1996, pp. 1596-1596
LONG-TERM SURVEILLANCE FOR HUMAN ANTIMURINE ANTIBODIES OF A GROUP OF HEMOPHILIACS TREATED ONLY WITH IMMUNOAFFINITY-PURIFIED FVIII CONCENTRATES
Authors: BRACKMANN HH GOMPERTS ED COURTER SC VIDOR A OBRIEN S OLDENBURG J
Citation: Hh. Brackmann et al., LONG-TERM SURVEILLANCE FOR HUMAN ANTIMURINE ANTIBODIES OF A GROUP OF HEMOPHILIACS TREATED ONLY WITH IMMUNOAFFINITY-PURIFIED FVIII CONCENTRATES, Haemophilia, 1(2), 1995, pp. 111-114
RESULTS FORM THE RECOMBINATE(TM) (RECOMBINANT FACTOR-VIII) STUDY OF PREVIOUSLY UNTREATED PATIENTS WITH HEMOPHILIA-A - A 4.5-YEAR FOLLOW-UP REPORT
Authors: BRAY GL SCHROTH P LYNES M BUCKWALTER C LEE ML GOMPERTS ED
Citation: Gl. Bray et al., RESULTS FORM THE RECOMBINATE(TM) (RECOMBINANT FACTOR-VIII) STUDY OF PREVIOUSLY UNTREATED PATIENTS WITH HEMOPHILIA-A - A 4.5-YEAR FOLLOW-UP REPORT, Thrombosis and haemostasis, 73(6), 1995, pp. 1013-1013
THE PHARMACOKINETICS OF RECOMBINANT FACTOR-VIII (RECOMBINATE(R)) UNDER CONTINUOUS-INFUSION
Authors: LEE M KESSLER C WHITE GC GOMPERTS ED COURTER SG
Citation: M. Lee et al., THE PHARMACOKINETICS OF RECOMBINANT FACTOR-VIII (RECOMBINATE(R)) UNDER CONTINUOUS-INFUSION, Thrombosis and haemostasis, 73(6), 1995, pp. 1015-1015
EVALUATION OF SOLVENT DETERGENT-TREATED FIBRIN SEALANT (HUMAN) VIRAL SAFETY IN PATIENTS UNDERGOING SKIN-GRAFT PROCEDURES
Authors: BRAY GL LEE M DEDRICK L GOMPERTS ED
Citation: Gl. Bray et al., EVALUATION OF SOLVENT DETERGENT-TREATED FIBRIN SEALANT (HUMAN) VIRAL SAFETY IN PATIENTS UNDERGOING SKIN-GRAFT PROCEDURES, Thrombosis and haemostasis, 73(6), 1995, pp. 1464-1464
THE BAXTER FIBRIN SEALANT
Authors: GOMPERTS ED MANKARIOUS S ALPERN M
Citation: Ed. Gomperts et al., THE BAXTER FIBRIN SEALANT, Thrombosis and haemostasis, 73(6), 1995, pp. 1472-1472
CONCORDANCE OF HUMAN-LEUKOCYTE ANTIGEN HAPLOTYPE-SHARING, CD4 DECLINEAND AIDS IN HEMOPHILIC SIBLINGS
Authors: KRONER BL GOEDERT JJ BLATTNER WA WILSON SE CARRINGTON MN MANN DL OBRIEN SJ WILLOUGHBY A KESSEL W DONFIELD SM MCKINLAY SM ALEDORT LM ARKIN S EYSTER ME PATTISHALL EG HILGARTNER MW KONKLE B WHITE GC COHEN AR BRAY GL LUBAN N KESSLER CM RAGNI MV LEDERMAN MM LEISSINGER C SIROIS P MANCOJOHNSON M DEMOERLOOSE P MAHE A HATZAKIS A MANDALAKI T SCHRAMM W EICHINGER S STINGL G GOMPERTS ED HOOTS WK LOVELAND KA KISKER CT STEHBENS AA CONTANT CF HUSZTI H SWINDELLS S MANGOS J WARRIER I SHAPIRO AD DAVIGNON GF WICKLUND BM WINKLER C
Citation: Bl. Kroner et al., CONCORDANCE OF HUMAN-LEUKOCYTE ANTIGEN HAPLOTYPE-SHARING, CD4 DECLINEAND AIDS IN HEMOPHILIC SIBLINGS, AIDS, 9(3), 1995, pp. 275-280
TRANSIENT INHIBITORS IN RECIPIENTS OF RECOMBINANT FACTOR-VIII (R-FVIII) - A REPORT FROM THE RECOMBINATE(TM) STUDY OF PREVIOUSLY UNTREATED PATIENTS (PUPS)
Authors: GRUPPO R BRAY GL SCHROTH P GOMPERTS ED ALEDORT L
Citation: R. Gruppo et al., TRANSIENT INHIBITORS IN RECIPIENTS OF RECOMBINANT FACTOR-VIII (R-FVIII) - A REPORT FROM THE RECOMBINATE(TM) STUDY OF PREVIOUSLY UNTREATED PATIENTS (PUPS), Blood, 86(10), 1995, pp. 758-758
COMPARISON OF HALF-LIFE OF METHOD-M PURIFIED AHG (HEMOFIL-M) BY ONE-STAGE AND CHROMOGENIC SUBSTRATE ASSAY-METHODS
Authors: LEE CA PASI KJ OWENS D BARROCLIFFE T COOK GK BRAY G VANTILBOURG L LEE M GOMPERTS ED
Citation: Ca. Lee et al., COMPARISON OF HALF-LIFE OF METHOD-M PURIFIED AHG (HEMOFIL-M) BY ONE-STAGE AND CHROMOGENIC SUBSTRATE ASSAY-METHODS, Blood, 86(10), 1995, pp. 3500-3500
ZIDOVUDINE COMPARED WITH DIDANOSINE IN PATIENTS WITH ADVANCED HIV TYPE-1 INFECTION AND LITTLE OR NO PREVIOUS EXPERIENCE WITH ZIDOVUDINE
Authors: DOLIN R AMATO DA FISCHL MA PETTINELLI C BELTANGADY M LIOU SH BROWN MJ CROSS AP HIRSCH MS HARDY WD MILDVAN D BLAIR DC POWDERLY WG PARA MF FIFE KH STEIGBIGEL RT SMALDONE L CRUMPACKER CS COOLEY T MITSUYASO RT JOHN R SANDERS C REITMAN D HEWITT R REICHMAN RC GELB LD MCGUIRE ML JONES M NEIDIG JL ZWICKL B HARTMAN PB ROARKE ME BURK RA FUHRER J SOMOGYI KA SEPKOWITZ K TELZAK EE MCAULIFFE VJ VALENTINE FT VASQUEZ M MERIGAN TC KATZENSTEIN D FESSELL J HAVLIR DV RICHMAN DD SPECTOR SA KAHN JO JOHNSON L COLEMAN R HO M MCMAHON D PAZIN G ANTONISKIS D MCNAMARA B DIAMOND D COLLIER AC PARADISE MA WALD A DEPAOLISJONES A HENRY K WASKIN HA HYSLOP NE MUSHATT DM ZACHARY JA SOEIRO R HARRIS C ZINGMAN B GIORDANO MF SLEDZ S MURRAY HW CAREY JT DAVIS TL BAGBY B KESSLER HA MURPHY RL HIRSCHTICK RE CHEESEMAN SH LAI KK FAIRCHILD PG EHMANN WC ZURLO JJ MILLARD R TROIANI L HEGGEN AA VANDERHORST CM MCKINLEY GF GRIECO MH KOLATCH BR GOLDSMITH JC GOMPERTS ED WOODS LM GRUE L MAYJO K BECKER RL JAYAWEERA DT ROLFE L COLE J JERMANO J
Citation: R. Dolin et al., ZIDOVUDINE COMPARED WITH DIDANOSINE IN PATIENTS WITH ADVANCED HIV TYPE-1 INFECTION AND LITTLE OR NO PREVIOUS EXPERIENCE WITH ZIDOVUDINE, Archives of internal medicine, 155(9), 1995, pp. 961-974
DIFFERENTIAL-EFFECTS OF HIV-INFECTION ON T-HELPER(1) AND T-HELPER(2) LYMPHOCYTES OF HEMOPHILIC CHILDREN AND ADOLESCENTS
Authors: JASON J MURPHY J SLEEPER LA DONFIELD SM WARRIER I ARKIN S EVATT B GOMPERTS ED
Citation: J. Jason et al., DIFFERENTIAL-EFFECTS OF HIV-INFECTION ON T-HELPER(1) AND T-HELPER(2) LYMPHOCYTES OF HEMOPHILIC CHILDREN AND ADOLESCENTS, The FASEB journal, 8(4), 1994, pp. 10000494-10000494
IMMUNE AND SEROLOGIC PROFILES OF HIV-INFECTED AND NONINFECTED HEMOPHILIC CHILDREN AND ADOLESCENTS
Authors: JASON J MURPHY J SLEEPER LA DONFIELD SM WARRIER I ARKIN S EVATT B GOMPERTS ED
Citation: J. Jason et al., IMMUNE AND SEROLOGIC PROFILES OF HIV-INFECTED AND NONINFECTED HEMOPHILIC CHILDREN AND ADOLESCENTS, American journal of hematology, 46(1), 1994, pp. 29-35
HCV AND GAMMAGARD IN FRANCE
Authors: GOMPERTS ED
Citation: Ed. Gomperts, HCV AND GAMMAGARD IN FRANCE, Lancet, 344(8916), 1994, pp. 201-201
DELAYED SOMATIC GROWTH AND PUBERTAL DEVELOPMENT IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED HEMOPHILIAC BOYS - HEMOPHILIA GROWTH AND DEVELOPMENT STUDY
Authors: GERTNER JM KAUFMAN FR DONFIELD SM SLEEPER LA SHAPIRO AD HOWARD C GOMPERTS ED HILGARTNER MW
Citation: Jm. Gertner et al., DELAYED SOMATIC GROWTH AND PUBERTAL DEVELOPMENT IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED HEMOPHILIAC BOYS - HEMOPHILIA GROWTH AND DEVELOPMENT STUDY, The Journal of pediatrics, 124(6), 1994, pp. 896-902
ANAPHYLAXIS FOLLOWING THE USE OF RECOMBINANT FACTOR-VIII (RECOMBINATE, BAXTER-HYLAND)
Authors: SHOPNICK RI BRETTLER DB KAZEMI M GOMPERTS ED
Citation: Ri. Shopnick et al., ANAPHYLAXIS FOLLOWING THE USE OF RECOMBINANT FACTOR-VIII (RECOMBINATE, BAXTER-HYLAND), Blood, 84(10), 1994, pp. 10000467-10000467
A MULTICENTER STUDY OF RECOMBINANT FACTOR-VIII (RECOMBINATE) - SAFETY, EFFICACY, AND INHIBITOR RISK IN PREVIOUSLY UNTREATED PATIENTS WITH HEMOPHILIA-A
Authors: BRAY GL GOMPERTS ED COURTER S GRUPPO R GORDON EM MANCOJOHNSON M SHAPIRO A SCHEIBEL E WHITE G LEE M GORDON M BERTALONE S LIPTON R HILGARTNER M ARKIN S GILL J KIM H SHURIN S SANTIAGOBORRERO P ARKEL YS KULKARNI R GREENWOOD MF RITCHEY AK WERNER E HAIRE WD KISKER T NEUFELD E EWENSTEIN B DEBIASI R LAURIAN Y KREUZ W RODEGHIERO F INGERSLEV J GAZENGEL C DIMICHELE D COOPER H
Citation: Gl. Bray et al., A MULTICENTER STUDY OF RECOMBINANT FACTOR-VIII (RECOMBINATE) - SAFETY, EFFICACY, AND INHIBITOR RISK IN PREVIOUSLY UNTREATED PATIENTS WITH HEMOPHILIA-A, Blood, 83(9), 1994, pp. 2428-2435
Risultati: 1-25 | 26-26